MRI-guided localization of the dominant intraprostatic lesion and dose analysis of volumetric modulated arc therapy planning for prostate cancer.
Jörg TamihardjaMaria ZenkMichael FlentjePublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2018)
Up to 82.1% of histologically verified intraprostatic lesions were identified in the context of MRI-guided radiotherapy treatment planning. As expected, dorsal DIL tend to be minimally underdosed in comparison to ventral DIL. Adequate dose coverage was achieved in over 98% of patients.
Keyphrases
- prostate cancer
- end stage renal disease
- spinal cord
- magnetic resonance imaging
- contrast enhanced
- ejection fraction
- newly diagnosed
- chronic kidney disease
- early stage
- radical prostatectomy
- diffusion weighted imaging
- radiation therapy
- prognostic factors
- squamous cell carcinoma
- peritoneal dialysis
- healthcare
- neuropathic pain
- stem cells
- magnetic resonance
- locally advanced
- radiation induced
- spinal cord injury
- patient reported
- bone marrow